Frequency of progression to undergo HCT and reasons documented for failure to proceed to undergo HCT among the subgroup of patients treated based on AML vs ALL
| . | AML (N = 171) . | ALL (N = 73) . | P value . |
|---|---|---|---|
| Number of patients proceeding to undergo HCT | 93 (54%) | 45 (62%) | .30 |
| Reasons for failure to proceed to HCT | (N = 78) | (N = 28) | |
| Comorbidities | 27 (35%) | 13 (46%) | .27 |
| KPS | 17 (22%) | 4 (14%) | .39 |
| Caregiver issues | 14 (18%) | 6 (21%) | .69 |
| Refractory disease | 20 (26%) | 1 (4%) | .012 |
| Patient declined | 13 (17%) | 5 (18%) | .89 |
| Induction death | 6 (8%) | 3 (11%) | .62 |
| . | AML (N = 171) . | ALL (N = 73) . | P value . |
|---|---|---|---|
| Number of patients proceeding to undergo HCT | 93 (54%) | 45 (62%) | .30 |
| Reasons for failure to proceed to HCT | (N = 78) | (N = 28) | |
| Comorbidities | 27 (35%) | 13 (46%) | .27 |
| KPS | 17 (22%) | 4 (14%) | .39 |
| Caregiver issues | 14 (18%) | 6 (21%) | .69 |
| Refractory disease | 20 (26%) | 1 (4%) | .012 |
| Patient declined | 13 (17%) | 5 (18%) | .89 |
| Induction death | 6 (8%) | 3 (11%) | .62 |